Josiane Pillonel
YOU?
Author Swipe
View article: Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal <scp>RNA</scp> screening in France
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal <span>RNA</span> screening in France Open
Background and Objectives The risk of a blood donation contaminated with hepatitis E virus (HEV) entering the blood supply before introducing universal HEV‐RNA screening in France was estimated to assess the benefit of such a measure. Mate…
View article: Insights on 21 Years of HBV Surveillance in Blood Donors in France
Insights on 21 Years of HBV Surveillance in Blood Donors in France Open
Hepatitis B virus (HBV) infection is the most frequent viral infection found in blood donors (BDs) in France. We analyzed the epidemiological and sero-molecular data on HBV infection gathered over the past two decades by the French haemovi…
View article: Use of healthcare reimbursement data to monitor bacterial sexually transmitted infection testing in France, 2006 to 2020
Use of healthcare reimbursement data to monitor bacterial sexually transmitted infection testing in France, 2006 to 2020 Open
Background Diagnoses of bacterial sexually transmitted infections (STIs) have increased in France since the 2000s. The main strategy to control STI transmission is recommending/facilitating access to condom use, testing, and antibiotic tre…
View article: SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network.
SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network. Open
SARS-CoV-2 RNA can be detected in a small fraction of blood donors with PDI, reporting very low levels of RNA. The corresponding plasma is probably not infectious. These findings highlight the value of haemovigilance and PDI to guide blood…
View article: Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France.
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France. Open
The decline in HCV-NAT yield cases raises the question of the relevance of NAT. Conversely, the increase in Ab+/NAT-donors, suggesting a growing number of resolved infections, argue for Ab discontinuation. In our experience, at least 0.5% …
View article: DGVRetroDon : contribution à l’évaluation du risque de transmission du SARS-CoV-2 par transfusion par un dépistage de l’ARN viral plasmatique dans des dons de sang en France
DGVRetroDon : contribution à l’évaluation du risque de transmission du SARS-CoV-2 par transfusion par un dépistage de l’ARN viral plasmatique dans des dons de sang en France Open
View article: French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long Open
View article: French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long Open
Background: Hepatitis C virus (HCV) elimination by 2030, as targeted by the World Health Organization (WHO), requires that 90% of people with chronic infection be diagnosed and 80% treated. We estimated the cascade of care (CoC) for chroni…
View article: French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long Open
Background: Hepatitis C virus (HCV) elimination by 2030, as targeted by the World Health Organization (WHO), requires that 90% of people with chronic infection be diagnosed and 80% treated. We estimated the cascade of care (CoC) for chroni…
View article: No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation Open
The risk of transfusion-associated transmission of SARS-CoV-2 is unknown. Cappy and colleagues report on hemovigilance studies of 268 blood donations from individuals reporting symptoms shortly after donation. Of 268 samples, 3 tested posi…
View article: Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study
Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study Open
View article: French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long
French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long Open
Background: Hepatitis C virus (HCV) elimination by 2030, as targeted by the World Health Organization (WHO), requires that 90% of people with chronic infection be diagnosed and 80% treated. We estimated the cascade of care (CoC) for chroni…
View article: The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France
The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France Open
BACKGROUND Blood donation deferral for men who have sex with men (MSM) in France was reduced from permanent to 12 months in July 2016. To inform a further reduction of the deferral period, an HIV risk assessment was conducted with two scen…
View article: HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy Open
Background The advent of effective direct-acting antivirals (DAAs), has prompted an assessment of the French Hepatitis C virus (HCV) screening strategy, which historically targeted high-risk groups. One of the options put forward is the im…
View article: Antenatal HIV screening: results from the National Perinatal Survey, France, 2016
Antenatal HIV screening: results from the National Perinatal Survey, France, 2016 Open
Background Universal antenatal HIV screening programmes are an effective method of preventing mother-to-child transmission. Aims To assess the coverage and yield of the French programme on a nationally representative sample of pregnant wom…
View article: HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy Open
Background: The advent of effective direct-acting antivirals (DAAs), has prompted an assessment of the French Hepatitis C virus (HCV) screening strategy, which historically targeted high-risk groups. One of the options put forward is the i…
View article: HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy Open
Background: The advent of effective direct-acting antivirals (DAAs), has prompted an assessment of the French Hepatitis C virus (HCV) screening strategy, which historically targeted high-risk groups. One of the options put forward is the i…
View article: HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy
HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy Open
Background The advent of effective direct-acting antivirals (DAAs), has prompted an assessment of the French Hepatitis C virus (HCV) screening strategy, which historically targeted high-risk groups. One of the options put forward is the im…
View article: Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework.
Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework. Open
The assessments considered in each country were generally consistent with the assessments recommended by the Framework. When data supported quantified risk assessment, safety and operational feasibility had the greatest weight. When risk w…
View article: Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016
Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016 Open
Diagnoses of bacterial sexually transmitted infections (STI) have been increasing in France since their resurgence in the late 1990s. This article presents recent epidemiological trends until 2016 and the patients’ characteristics. STI sur…
View article: Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey)
Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey) Open
Seroprevalence estimation using cross-sectional serosurveys can be challenging due to inadequate or unknown biological cut-off limits of detection. In recent years, diagnostic assay cut-offs, fixed assay cut-offs and more flexible approach…
View article: Assessing the cost-effectiveness of hepatitis C screening strategies in France
Assessing the cost-effectiveness of hepatitis C screening strategies in France Open
View article: Revealing geographical and population heterogeneity in<scp>HIV</scp>incidence, undiagnosed<scp>HIV</scp>prevalence and time to diagnosis to improve prevention and care: estimates for France
Revealing geographical and population heterogeneity in<span>HIV</span>incidence, undiagnosed<span>HIV</span>prevalence and time to diagnosis to improve prevention and care: estimates for France Open
Introduction To close gaps in HIV prevention and care, knowledge about locations and populations most affected by HIV is essential. Here, we provide subnational and sub‐population estimates of three key HIV epidemiological indicators, whic…
View article: Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015
Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015 Open
Successive advances in HCV treatment have been rapidly and widely implemented in France. With the announcement of universal access to DAAs in mid-2016 and price reductions, access to 2nd-wave DAAs is expected to expand even more.
View article: New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004–15: an analysis of surveillance data
New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004–15: an analysis of surveillance data Open
View article: Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France
Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France Open
BACKGROUND In France, information collected during postdonation interviews showed that a majority of human immunodeficiency virus (HIV)‐infected donors were not eligible to donate as per donor selection criteria. In the interest of blood s…
View article: Changes in France’s Deferral of Blood Donation by Men Who Have Sex with Men
Changes in France’s Deferral of Blood Donation by Men Who Have Sex with Men Open
International audience
View article: Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011–2013
Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011–2013 Open
SUMMARY People who use drugs (PWUD) are a key population for hepatitis B virus (HBV) vaccination and screening. We aimed to estimate the seroprevalence of HBs antigen (HBsAg) and self-reported HBV vaccination history in French PWUD attendi…
View article: Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004–2011: model-based estimation from two national cross-sectional serosurveys
Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004–2011: model-based estimation from two national cross-sectional serosurveys Open
SUMMARY Hepatitis C virus (HCV) infection is a public health issue worldwide. Injecting drug use remains the major mode of transmission in developed countries. Monitoring the HCV transmission dynamic over time is crucial, especially to ass…
View article: The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014
The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014 Open
Many individuals were still undiagnosed in 2014 despite a marked reduction with respect to 2004. The present work contributed to the 2014 recommendation of a new French complementary screening strategy, consisting in one-time simultaneous …